CurveBeam AI (ASX:CVB) Capex-to-Operating-Income : 0.00 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

CurveBeam AI's Capital Expenditure for the six months ended in Dec. 2023 was A$-0.08 Mil. Its Operating Income for the six months ended in Dec. 2023 was A$-13.59 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.

CurveBeam AI Capex-to-Operating-Income Historical Data

The historical data trend for CurveBeam AI's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI Capex-to-Operating-Income Chart

CurveBeam AI Annual Data

Trend

Jun21

Jun22

Jun23

Capex-to-Operating-Income

CurveBeam AI Semi-Annual Data
	Jun21	Dec21	Jun22	Jun23	Dec23
Capex-to-Operating-Income	-	-	-	-	-

Competitive Comparison of CurveBeam AI's Capex-to-Operating-Income

For the Medical Devices subindustry, CurveBeam AI's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CurveBeam AI's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where CurveBeam AI's Capex-to-Operating-Income falls into.

CurveBeam AI Capex-to-Operating-Income Calculation

CurveBeam AI's Capex-to-Operating-Income for the fiscal year that ended in Jun. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-0.842)	/	-18.756
	=	N/A

CurveBeam AI's Capex-to-Operating-Income for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-0.082)	/	-13.593
	=	N/A

CurveBeam AI (ASX:CVB) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

CurveBeam AI Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

CurveBeam AI (ASX:CVB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000

Website

https://www.curvebeamai.com

CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines